Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.

Expert review of molecular diagnostics - 1 Mar 2026

Singh Pushpendra, Sharma Kuldeep, Tamrakar Vaibhav K, Khare Ruchi, Bhargava Anudita, Negi Sanjay Singh

Abstract excerpt

INTRODUCTION: The CRISPR/Cas system has emerged as a highly versatile platform for diagnosing infectious diseases, particularly viral pathogens. Human papillomavirus (HPV) comprises of more than 200 types, with persistent infection by 14 high-risk genotypes recognized as the primary cause of cervical cancer worldwide. Early and accurate detection of these High-Risk HPV (HR-HPV) types is essential for effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Papillomavirus Viruses

Share to Molecular Diagnostic Techniques

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 41919328
DOI: 10.1080/14737159.2026.2654503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.PMID 41919328Read ↗

Development and evaluation of a CRISPR/Cas12a-based diagnostic test for rapid detection and genotyping of HR-HPV in clinical specimensSemantic proximity Read ↗

CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care DiagnosticsSemantic proximity Read ↗

A One-Pot CRISPR/Cas9-Typing PCR for DNA Detection and Genotyping.Semantic proximity Read ↗

Rapid detection of HPV16/18 based on a CRISPR-Cas13a/Cas12a dual-channel systemSemantic proximity Read ↗

A high fidelity CRISPR/Cas12a based lateral flow biosensor for the detection of HPV16 and HPV18Semantic proximity Read ↗

Development of a CRISPR/dCas9-based membrane-assisted colorimetric assay for detection of high-risk HPV16 and HPV18: a proof-of-concept study.Semantic proximity Read ↗

A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes.Semantic proximity Read ↗

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatmentSemantic proximity Read ↗

CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection methodSemantic proximity Read ↗

Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensorsSemantic proximity Read ↗

One-Pot Isothermal Linear Amplification and Cas12a-based Nucleic Acid DetectionSemantic proximity Read ↗

Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12aSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.